Securing Scientific Integrity
EPN Comments on NASEM Charge Questions and Ad Hoc Committee for “State-of-the-Science and the Future of Cumulative Impact Assessment”
EPN Submits Nominees for FY2025 Clean Air Scientific Advisory Committee Membership
EPN Comments on EPA’s Draft Scientific Integrity Policy
EPN Comments on New Approach Methodologies in the Endocrine Disruptor Screening Program
Letter to Administrator Regan Regarding Best Available Science
EPN Welcomes Senate Confirmation of ORD Assistant Administrator After 10-Year Vacancy
Comments on the Development of a Federal Scientific Integrity Policy Framework
Testimony on CASAC’s Draft Reports on EPA’s Draft Supplement to the 2019 ISA and Draft PA for Particulate Matter
EPN IN THE NEWS RELATED TO Science
Dismantling EPA’s Research Office Jeopardizes Environmental Safety, Public Health, and US Competitiveness
June 11, 2025 / by
Scott Glaberman, H. Christopher Frey, and Tamara Tal /
Proceedings of the National Academy of Sciences
Chris Frey, former Assistant Administrator, EPA Office of Research and Development, co-authored an op-ed published in Proceedings of the National Academy of Sciences. Recent reports suggest that the Trump administration plans to eliminate EPA’s Office of Research and Development.
‘Gold Standard Science’ May Lead to Discarding Valid Research
Andy Miller, former Senior Science Advisor, EPA Office of Research and Development, was quoted in Chemical and Engineering News. Trump’s executive order gives political appointees power to enforce standards that scientists call unattainable.
Senators Face Pressure to Safeguard EPA Research Arm
Chris Frey, former Assistant Administrator, EPA Office of Research and Development, was quoted in E&E News. Calling the Office of Research and Development “a unique national asset,” former agency research chiefs appealed to appropriators against downsizing.
EPA Cancels Key Science Advisory Board Meeting
Jeremy Symons, Senior Adviser to EPN, was quoted in Inside Climate News. The cancellation of a meeting of top advisors to the agency’s scientific research arm, with no explanation or plans to reschedule, signals bad news for public health and the environment, say former advisors.